Associated Papers
Whole exome sequencing diagnosing syndromic and non-syndromic hearing loss with expansion of the phenotypic spectrum related to TMC1 variants.
Elbagoury NM et al.
European Journal of Pediatrics, 2025
The Prevalence and Clinical Characteristics of MYO3A-Associated Hearing Loss in 15,684 Hearing Loss Patients.
Maekawa K et al.
Genes, 2025
Pathophysiology of human hearing loss associated with variants in myosins.
Miyoshi T et al.
Frontiers in Physiology, 2024
Frequency and origin of the c.2090T>G p.(Leu697Trp) MYO3A variant associated with autosomal dominant hearing loss.
Bueno AS et al.
European Journal of Human Genetics : Ejhg, 2022
Molecular insights into MYO3A kinase domain variants explain variability in both severity and progression of DFNB30 hearing impairment.
Souissi A et al.
Journal of Biomolecular Structure & Dynamics, 2022
Functional Role of Class III Myosins in Hair Cells.
Cirilo JA et al.
Frontiers in Cell and Developmental Biology, 2021
A novel missense variant in MYO3A is associated with autosomal dominant high-frequency hearing loss in a German family.
Doll J et al.
Molecular Genetics & Genomic Medicine, 2020
Myosins and Disease.
Coluccio LM
Advances in Experimental Medicine and Biology, 2020
Systematic Review of Hearing Loss Genes in the African American Population.
Worden CP et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2019
Characterization of a novel MYO3A missense mutation associated with a dominant form of late onset hearing loss.
Dantas VGL et al.
Scientific Reports, 2018
The genetic basis of deafness in populations of African descent.
Rudman JR et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2017
MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform.
Grati M et al.
Human Mutation, 2016